Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Michael R. Migden"'
Autor:
Leonel Hernandez-Aya, Michael R. Migden, Aleksandar Sekulic, Oliver Bechter, Rogerio I. Neves, Kosalai Kal Mohan, Timothy Bowler, Axel Hauschild, Zeynep Eroglu, Ketty Peris, David M. Weinreich, Israel Lowy, Lisa Licitra, Siyu Li, Karl D. Lewis, Jean-François Baurain, Frank Seebach, Marcus O. Butler, Lara Dunn, George D. Yancopoulos, Emily S. Ruiz, Ebony Coates, Anne Lynn S. Chang, Emmanuel Okoye, Matthew G. Fury, Alexander J. Stratigos
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Background HHIs, vismodegib and sonidegib, are approved for treatment of patients with mBCC or locally advanced BCC who are not candidates for surgery or radiation. There is no approved option for patients who progress on or are intolerant to HHIs. C